Quote:Max Lataillade Architect of ViiV's long-acting pipeline. He is at CytoDyn to ensure Leronlimab fits the GSK/Shionogi ULA (Ultra-Long-Acting) mandate.
That's stated as fact. For new investors that is misleading.
For long time longs it is disquieting since it's not based on facts.
Have you met Max? Are you an insider? C'mon man...
Maybe it's a semantics thing but using disclaimers such as:
"This is what the facts are leading me to believe..."
or
"I'm of the opinion that..."
or
"Here's a wild ass guess as to what's going on behind closed doors..."
helps appropriately characterize the discussion.
I'm not the only one who is pointing up this disconnect between fact and opinion to you. In the end you could be batting one thousand/pitching a perfect game, but for now we are, as a collective, not dialed in to wtf is actually transpiring behind closed doors. Conjecture is fun, and I engage in it constantly with a shockingly low batting average, but I characterize it as such when I do it. Educated conjecture/connecting the dots? Even better. But it's conjecture none the less.